Sign in

CIK 0000907654

  • Non-accelerated filer
  • Smaller reporting company

Oruka Therapeutics, Inc.

Sign in to watch
Ticker
ORKA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
363855489
Phone
+1 650-606-7910
Business address
855 OAK GROVE AVE., SUITE 100, MENLO PARK, CA, 94025
Former names
ARCA biopharma, Inc., NUVELO INC, HYSEQ INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$20,577,126
in 17 filings, $20.2M under 10b5-1 plans

Net −$20,577,126. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2018-02-26 MOTT DAVID M 10% owner Sale −1,460,209 $0.50 $731K 0
2018-02-26 MAKOWER JOSHUA 10% owner Sale −1,460,209 $0.50 $731K 0
2018-02-26 Florence Anthony A. Jr. 10% owner Sale −1,460,209 $0.50 $731K 0
2018-02-26 BASKETT FOREST 10% owner Sale −1,460,209 $0.50 $731K 0
2018-02-26 BARRIS PETER J 10% owner Sale −1,460,209 $0.50 $731K 0
2018-02-26 Growth Equity Opportunities IV, LLC 10% owner Sale −1,460,209 $0.50 $731K 0
2017-07-14 CONWAY ROBERT E Director Purchase +10,000 $2.49 $25K 35,000
2017-05-02 MITCHELL DANIEL J Director Purchase +11,000 $2.71 $30K 11,000
2017-04-04 Ozeroff Christopher David S.V.P., General Counsel Sale −418 $2.41 $1K 17,517
2017-04-04 Keuer Thomas A Chief Operating Officer Sale −390 $2.41 $940 14,045
2017-04-04 BRISTOW MICHAEL R Pres. & Chief Executive Offic Sale −720 $2.41 $2K 41,155
2017-04-03 Selby Brian L. VP, Finance Sale −1,114 $2.46 $3K 1,275
2017-03-24 CONWAY ROBERT E Director Purchase +25,000 $2.59 $65K 25,000
2017-02-28 Ozeroff Christopher David S.V.P., General Counsel Sale −465 $2.61 $1K 17,935
2017-02-28 Keuer Thomas A Chief Operating Officer Sale −465 $2.61 $1K 14,435
2017-02-28 BRISTOW MICHAEL R Pres. & Chief Executive Offic Sale −763 $2.61 $2K 41,875
2017-02-27 Selby Brian L. VP, Finance Sale −161 $2.56 $412 2,389
2017-02-27 Selby Brian L. VP, Finance Grant or award · Stock Option (right to buy) +24,100 24,100
2017-02-27 Ozeroff Christopher David S.V.P., General Counsel Grant or award · Stock Option (right to buy) +22,700 22,700
2017-02-27 Keuer Thomas A Chief Operating Officer Grant or award · Stock Option (right to buy) +23,800 23,800

Page 21 of 24 · 473 trades